WoodTrust Financial Corp Grows Stock Position in Neogen Co. (NASDAQ:NEOG)

WoodTrust Financial Corp boosted its stake in shares of Neogen Co. (NASDAQ:NEOG) by 9.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 61,100 shares of the company’s stock after acquiring an additional 5,175 shares during the quarter. WoodTrust Financial Corp’s holdings in Neogen were worth $742,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of NEOG. Citigroup Inc. lifted its position in Neogen by 129.1% in the third quarter. Citigroup Inc. now owns 231,833 shares of the company’s stock valued at $3,897,000 after purchasing an additional 130,641 shares during the last quarter. American Capital Management Inc. raised its holdings in Neogen by 36.5% during the 3rd quarter. American Capital Management Inc. now owns 3,414,700 shares of the company’s stock valued at $57,401,000 after buying an additional 913,604 shares during the last quarter. State Street Corp boosted its position in Neogen by 3.1% during the 3rd quarter. State Street Corp now owns 7,932,192 shares of the company’s stock valued at $133,340,000 after buying an additional 236,762 shares during the period. Private Advisor Group LLC grew its holdings in Neogen by 135.3% in the 4th quarter. Private Advisor Group LLC now owns 67,298 shares of the company’s stock worth $817,000 after acquiring an additional 38,703 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Neogen by 17.9% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 38,166 shares of the company’s stock valued at $642,000 after acquiring an additional 5,804 shares during the period. 96.73% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CEO John Edward Adent acquired 23,035 shares of the stock in a transaction on Thursday, January 16th. The stock was acquired at an average price of $11.03 per share, with a total value of $254,076.05. Following the completion of the transaction, the chief executive officer now owns 269,164 shares of the company’s stock, valued at $2,968,878.92. This represents a 9.36 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO David H. Naemura bought 14,800 shares of the company’s stock in a transaction dated Thursday, January 16th. The shares were acquired at an average price of $11.11 per share, for a total transaction of $164,428.00. Following the acquisition, the chief financial officer now owns 61,434 shares in the company, valued at approximately $682,531.74. This represents a 31.74 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 1.13% of the company’s stock.

Neogen Stock Up 2.0 %

Shares of Neogen stock opened at $9.60 on Wednesday. The company has a current ratio of 3.77, a quick ratio of 2.46 and a debt-to-equity ratio of 0.33. Neogen Co. has a 12-month low of $9.01 and a 12-month high of $18.58. The company has a market cap of $2.08 billion, a P/E ratio of -4.38 and a beta of 1.23. The company’s fifty day simple moving average is $11.24 and its two-hundred day simple moving average is $13.62.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings results on Friday, January 10th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.12. Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. The company had revenue of $231.30 million for the quarter, compared to analysts’ expectations of $227.16 million. During the same quarter in the previous year, the company earned $0.11 earnings per share. Neogen’s quarterly revenue was up .7% on a year-over-year basis. Research analysts anticipate that Neogen Co. will post 0.38 EPS for the current year.

Analysts Set New Price Targets

NEOG has been the subject of a number of analyst reports. Piper Sandler reiterated a “neutral” rating and set a $13.00 target price (down from $16.50) on shares of Neogen in a report on Tuesday, January 21st. Guggenheim began coverage on Neogen in a report on Thursday, December 19th. They issued a “buy” rating and a $15.00 price objective for the company.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.